Oncology

HR+/HER2- Early Breast Cancer

Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at ASCO 2026

conference reporter by Harold J. Burstein, MD, PhD; Joseph A. Sparano, MD, FACP

Overview

Conference Reporter delivers health care providers with insights from key thought leaders on exciting news presented at major medical conferences, in a concise and timely format. Conference Reporter will feature community-selected experts and topics in HR+/HER2- Early Breast Cancer presented at the 2026 ASCO Annual Meeting.

VIEW THE TOPICS:

Coming Soon.

This information is brought to you by Engage Health Media and is not sponsored, endorsed, or accredited by the American Society of Clinical Oncology.

2026 ASCO Annual Meeting

May 29 – June 2, 2026

McCormick Place, Chicago, IL & Online

Link to Registration

Profile

Harold J. Burstein, MD, PhD

Director of Academic Partnerships
Institute Physician
Dana-Farber Cancer Institute
Professor of Medicine
Harvard Medical School
Boston, MA

Profile

Joseph A. Sparano, MD, FACP

Ezra M. Greenspan, MD Professor in Clinical Cancer Therapeutics
Chief, Division of Hematology and Medical Oncology
Deputy Director
The Tisch Cancer Institute
Icahn School of Medicine at Mount Sinai
New York, NY

Oncology

HR+/HER2- Early Breast Cancer

Conference Reporter® in HR+/HER2- Early Breast Cancer to Cover Key Topics Being Presented at ASCO 2026

Harold J. Burstein, MD, PhD

Joseph A. Sparano, MD, FACP

Explore More in HR+/HER2- Early Breast Cancer

The Multidisciplinary Care of Patients With Early-Stage Breast Cancer

Surveillance Expectations for Early-Stage Breast Cancer

Adjuvant CDK4/6 Inhibitors for HR+/HER2- Early-Stage Breast Cancer: Who Should Get Them and How Toxicity Should Be Managed

Breast Cancer Risk Assessment and Reduction Strategies